AgroSpheres today announced a strategic alliance with Orion Integrated Biosciences to create the next generation of environmentally friendly, cost-effective and reliable RNAi pesticide products.

TearSolutions, Inc. announced today the successful completion and preliminary outcomes of a Phase I/II trial of LacripepTM in Primary Sjögren’s Syndrome (PSS) patients.

Icarus Medical Innovations Reveals The Ascender, A Revolutionary Knee Brace that Aims to Change the Future of Aging Athletics and those who Suffer from Osteoarthritis.

By: Whitelaw Reid, UVA Today People of a certain age may be familiar with the line from the television commercial, “I’ve fallen and I can’t get up.” The ad was...

AgroSpheres, a leader in developing the next generation of environmentally friendly crop protection products, announced today that it has extended its Series A to $8.8 million in financing.

Next Gen Nutrition Investment Fund, LP (NGN) is pleased to announce a strategic investment in Bonumose LLC, which has developed and patented an enzymatic technology platform for continuous production of...

The FDA has cleared HemoShear to begin a phase 2 clinical study of oral drug HST5040 for treating patients with rare metabolic diseases MMA and PA.

Bryan Berger, an associate professor of chemical engineering at UVA and CEO of Lytos Tech, received funding for research related to fighting the COVID-19 pandemic.

The new Commonwealth Research Commercialization Fund, administered by Virginia’s Center for Innovative Technology (CIT), announces awards, including Charlottesville BioHub companies AgroSpheres, Babylon Microfarms and KeViRx.

The selected startups will conduct research and development activities at the Donald Danforth Plant Science Center in St. Louis, a program partner and the world’s largest independent plant science institute.

AMPEL BioSolutions announces genomic analysis and findings that could improve treatment of COVID19 patients with approved drugs such as Embrel and Stelara.

Planned study features noted principal investigator, regulatory flexibility, and immediate availability of patients.